Healthcare & Life Sciences

Replicate Bioscience

United States

series-a

Stage

Investors

About

Replicate Bioscience develops self-replicating RNA (srRNA) vaccine candidates and platform technologies targeting infectious diseases such as tuberculosis, HIV, and malaria.

Explore Replicate Bioscience's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.